14 hrs ago | Free Republic
B vitamin outperforms another drug in keeping arteries clear
Adding a pharmaceutical form of the B vitamin niacin - but not the drug ezetimibe - to a cholesterol-lowering statin drug appears to reduce artery plaque buildup in patients with coronary artery disease, according to much-anticipated results announced at a press conference November 15.
Yesterday | The Motley Fool
4-Star Stocks Poised to Pop: Merck
Based on the aggregated intelligence of 140,000-plus investors participating in Motley Fool CAPS , the Fool's free investing community, drug behemoth Merck has earned a respected four-star ranking .
EMEA's CHMP recommends approval of Merck's ELONVA
Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of ELONVAA as a treatment in controlled ovarian stimulation in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology ...
Ligand Pharmaceuticals receives $2 million from research partnership with Merck
Ligand Pharmaceuticals Inc. said Thursday it received a $2 million milestone payment from Merck & Co.
Answering The Vytorin Question
A trial showing that a form of niacin cleared arteries far better than Merck's Zetia cholesterol pill could have been disaster for the big drug maker.
15:04]( ... )- ' ' s Y - Y - BW-Higher Dose of Merck's COZAAR...
I'I I'IsIYI I I©I I- I I I IYI - BW-Higher Dose of Merck's COZAARA Signifi... src="http://mms.businesswire.com/bwapps/mediaserver/ViewMedia?mgid=57257&vid=2"> Nov.
New Study Raises New Questions About Cholesterol Drug Zetia
A new study raises more questions about ezetimibe , a drug used by millions of Americans in tandem with statins to lower LDL, or "bad," cholesterol.
How Merck Lost $2.3B in the Bermuda Triangle
Merck must pay $2.3 billion in tax following a dispute with the IRS over cash the company parked in the Caribbean.
Applied Materials, Merck and Braunschweig University Awarded Funding...
Applied Materials, Merck and Braunschweig University Awarded Funding by German Government for OLED Research Applied Materials, Inc., Merck KGaA and the Braunschweig University of Technology today announced that they have been awarded a grant by Germany's Federal Ministry of Education and Research to develop processes to lower the cost of ...
Even a small study on Zetia, Vytorin makes a big impact
It isn't often that a study involving a couple of hundred people shakes up medical science.
Study raises new questions about Merck pill Zetia
A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.
Definition Gout is a complex form of arthritis characterized by sudden, severe attacks of pain, redness and tenderness in joints, often the joint at the base of the big toe.
Merck Strengthens Its Commitment to Advancing Cardiovascular Health Care
Nov 14, 2009 - Following the completion of its merger with Schering-Plough, Merck today confirms and underscores its commitment to marketing and developing cardiovascular medicines for a range of cardiovascular disorders.
Merck enrolls patients in late-stage trial for heart attack-preventing drug
WHITEHOUSE STATION, N.J. Merck & Co. has enrolled more than 26,000 patients in a late-stage clinical trial of a drug for preventing heart attacks, the pharmaceutical company announced Friday.
Merck CEO Clark Eyes Retirement, and a $23M Golden Handshake
With the Schering-Plough merger done, Merck CEO Richard Clark is already mulling who will succeed him in the bosses' chair.
New Merck begins world operations
Wednesday, November 04 14:23:26 The new Merck and Co, a product of the merger between Merck Sharp and Dohme and Schering-Plough and which employs 2,300 in Ireland, was launched globally today.
GTx loss widens in third quarter
GTx Inc. reported $3.6 million in third quarter revenue, a slight drop from the $3.8 million the company reported for the second quarter of 2009.
The newest drugs may not always be the best
Last year pharmaceutical companies spent more than $4 billion urging patients like you to "ask your doctor" about their drugs.
Pulte Homes, Merck, Garmin are big movers
The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange: NYSE: Pulte Homes Inc., up 32 cents at $9.55 Motorola, Alcoa, Procter & Gamble are big movers Motorola, Alcoa, Procter & Gamble are big movers The following stocks were among those that moved substantially or traded heavily ...
Pensions for top U.S. executive rose by an average of 19 percent last year, and more than 200 officers saw their retirement savings surge by as much as 50 percent, even as their companies stock prices fell, the Wall Street Journal reported on Monday.
Also on Topix